Literature DB >> 5673963

Streptokinase and deep vein thrombosis.

N L Browse, M L Thomas, H P Pim.   

Abstract

Five patients with deep vein thrombosis were given streptokinase. Five others with similar phlebograms were given anticoagulants, and the results assessed by examining changes in the iliac, femoral, and calf segments of the phlebograms when repeated 7-10 days later. Those of the anticoagulant group were unchanged. Four of the five given streptokinase had a reduction in the size and extent of their thrombosis. Fresh thrombus surrounded by flowing blood was lysed. Thrombus completely blocking a vein was not lysed.The indications for the use of streptokinase in deep vein thrombosis are reviewed.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5673963      PMCID: PMC1989599          DOI: 10.1136/bmj.3.5620.717

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results.

Authors:  M VERSTRAETE; A AMERY; J VERMYLEN
Journal:  Br Med J       Date:  1963-06-08

2.  The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.

Authors:  A J JOHNSON; W R McCARTY
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  The acutely swollen leg and deep vein thrombosis.

Authors:  S Sevitt
Journal:  Br J Surg       Date:  1967-10       Impact factor: 6.939

4.  The iliac compression syndrome.

Authors:  F B Cockett; M L Thomas
Journal:  Br J Surg       Date:  1965-10       Impact factor: 6.939

5.  Thrombolytic therapy with streptokinase using a standard dosage scheme.

Authors:  M Verstraete; J Vermylen; A Amery; C Vermylen
Journal:  Br Med J       Date:  1966-02-19

6.  Management of the source of pulmonary emboli: the value of phlebography.

Authors:  N L Browse; M L Thomas; M J Solan
Journal:  Br Med J       Date:  1967-12-09
  6 in total
  17 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Why thrombolytic therapy.

Authors:  S Sherry
Journal:  West J Med       Date:  1981-02

Review 3.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Comparison between sequelae of surgical and medical treatment of venous thromboembolism.

Authors:  A E Young; A L Thomas; N L Browse
Journal:  Br Med J       Date:  1974-10-19

Review 5.  Anticoagulant and thrombolytic drugs. II. Clinical aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Radiological diagnosis of deep vein thrombosis and its sequelae.

Authors:  M L Thomas
Journal:  Proc R Soc Med       Date:  1970-02

7.  Prophylaxis of pulmonary embolism.

Authors:  N L Browse
Journal:  Br Med J       Date:  1970-06-27

8.  Thrombolytic therapy.

Authors: 
Journal:  Br Med J       Date:  1968-12-21

9.  Repeated phlebographic examination during and after fibrinolytic therapy with streptokinase and urokinase.

Authors:  E Gmelin; W Theiss
Journal:  Cardiovasc Radiol       Date:  1978-07-25

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.